Código QR

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine

<p>Abstract</p> <p>Background</p> <p>Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate vaccine. A mixture of influenza...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Ross Ted M, Crevar Corey J
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2008-10-01
Series:Virology Journal
Acceso en liña:http://www.virologyj.com/content/5/1/131
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!